Evidence map›Paper›PMID 40800075›Full record

SynthesisFrontiers in health services2025

Equitable access to COVID-19 vaccines in Botswana: a scoping review.

John T Tlhakanelo, John Ele-Ojo Ataguba, Vincent Pagiwa, Nankie Ramabu, Khutsafalo Kadimo, Dintle Molosiwa, Grace Njeri Muriithi, Daniel Malik Achala, Elizabeth Naa Adukwei Adote, Chinyere Ojiugo Mbachu and 5 more

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

John T TlhakaneloDepartment of Family Medicine and Public Health, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
John Ele-Ojo AtagubaAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.
Vincent PagiwaOkavango Research Institute, University of Botswana, Maun, Botswana.
Nankie RamabuDepartment of Family Medicine and Public Health, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Khutsafalo KadimoDepartment of Library and Information Science, University of Botswana, Gaborone, Botswana.
Dintle MolosiwaDepartment of Family Medicine and Public Health, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Grace Njeri MuriithiAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.
Daniel Malik AchalaAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.
Elizabeth Naa Adukwei AdoteAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.
Chinyere Ojiugo MbachuDepartment of Community Medicine, University of Nigeria, Enugu, Nigeria.
Senait Alemayehu BeshahAfrican Health Economics and Policy Association (AfHEA), Accra, Ghana.
Nyasha MasukaDepartment of Public Health, Zimbabwe College of Public Health Physicians, Harare, Zimbabwe.
Chijioke Osinachi NwosuDepartment of Economics and Finance, University of the Free State, Bloemfontein, South Africa.
James AkaziliSchool of Public Health, C.K. Tedam University of Technology and Applied Sciences, Navrongo, Ghana.
Chikezie IfeanyiHealth Systems and Development Research Group, Veritas University Abuja, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite global market complexities, Botswana acquired about 2.6 million COVID-19 vaccine doses between March 2021 and March 2022, 76% of which were purchased while 24% were donations. Thus, the study was envisaged to aggregate evidence on the case of Botswana's COVID-19 vaccine access patterns, hesitancy, and uptake. Materials and methods: We conducted a scoping reviewof Botswana-based articles using a predetermined search strategy to search databases including Medline, CINAHL, Web of Science, PubMed, Scopus, and Google Scholar. The review included all the English-language written peer-reviewed and grey literature reporting on vaccination in Botswana, to broaden coverage in recognition of limited publications on COVID-19 vaccinartion in Botswana. Non-English articles were excluded due to limited translation resources. Due to the heterogeneity of studies, a narrative synthesis approach was used to collect, synthesize, and map the literature. Results: As of 31 December 2021, 80.6% of the Botswana national target of 1,390,856 people over 18 years had received at least one dose of a COVID-19 vaccine, while 71.9% were fully vaccinated. Various vaccine distribution channels were utilized, including public facilities and outreaches, to improve access and uptake of vaccines. COVID-19 vaccine acceptance was considered generally high (73.4% amongst adults), and found positively associated with the male gender, those with comorbidities, those with non-restrictive religious beliefs, and those aged 55-64 years who thought the vaccine was safe for use. COVID-19 vaccine delivery relied on existing Expanded Program on Immunization (EPI) structures and therefore experienced to existing EPI challenges including, lack of transport, shortage of human resources, and vaccine stock-outs. Conclusions: Under-performance of immunization programs at the district level, characterized by declining immunization coverage and inadequate outreach services, exacerbates disparities in vaccine access. Efforts to strengthen healthcare infrastructure and expand outreach services are essential for reaching populations with limited access to healthcare facilities, particularly in rural and hard-to-reach areas. Collaboration with other government entities and the private sector improved vaccine access.

Indexed as

BotswanaCOVID-19equitable accessuptakevaccine hesitancyvaccines

Identifiers

PMID40800075
PMCPMC12339540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.